FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma - The ASCO Post

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOZVpLU3NYV0pIMHJrYn…; target="_blank">FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>